Document is current
Any future updates will be listed below
-
Authors
Sutton, Thomas L.
Walker, Brett S.
Billingsley, Kevin G.
Sheppard, Brett C.
Corless, Christopher L.
Heinrich, Michael C.
Mayo, Skye C.
- License Information
-
More Information
Article History
Received: 20 January 2021
Accepted: 4 April 2021
First Online: 9 May 2021
Disclosure
: Michael Heinrich is a consultant for Blueprint Medicines, Deciphera Pharmaceuticals, Novartis, and Theseus. Thomas L. Sutton, Brett S. Walker, Kevin G. Billingsley, Brett C. Sheppard, Christopher L. Corless, and Skye C. Mayo have no conflicts of interest to declare.
